Carrimycin Unknown Status Phase 4 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04286503
The Clinical Study of Carrimycin on Treatment Patients With COVID-19